Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes

NCT00982254 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Oral insulin
DRUG: regular human insulin

Sponsor

Profil Institut für Stoffwechselforschung GmbH

Collaborators

[object Object]